nodes	percent_of_prediction	percent_of_DWPC	metapath
Decamethonium—ACHE—breast cancer	0.486	0.63	CbGaD
Decamethonium—BCHE—breast cancer	0.286	0.37	CbGaD
Decamethonium—ACHE—Irinotecan—breast cancer	0.0577	0.624	CbGbCtD
Decamethonium—BCHE—Irinotecan—breast cancer	0.0348	0.376	CbGbCtD
Decamethonium—CHRNE—pituitary gland—breast cancer	0.00473	0.156	CbGeAlD
Decamethonium—CHRNG—nipple—breast cancer	0.00432	0.143	CbGeAlD
Decamethonium—CHRNA2—mammary gland—breast cancer	0.00287	0.0948	CbGeAlD
Decamethonium—CHRNG—adipose tissue—breast cancer	0.00235	0.0777	CbGeAlD
Decamethonium—CHRNG—bone marrow—breast cancer	0.00204	0.0674	CbGeAlD
Decamethonium—Succinylcholine—BCHE—breast cancer	0.00157	0.583	CrCbGaD
Decamethonium—CHRNA1—endocrine gland—breast cancer	0.00121	0.04	CbGeAlD
Decamethonium—CHRNB1—adipose tissue—breast cancer	0.0012	0.0397	CbGeAlD
Decamethonium—Sodium lauryl sulfate—ALB—breast cancer	0.00112	0.417	CrCbGaD
Decamethonium—CHRNB1—adrenal gland—breast cancer	0.00108	0.0356	CbGeAlD
Decamethonium—CHRNB1—female gonad—breast cancer	0.00101	0.0332	CbGeAlD
Decamethonium—CHRNA2—endocrine gland—breast cancer	0.00101	0.0332	CbGeAlD
Decamethonium—BCHE—nipple—breast cancer	0.000942	0.0311	CbGeAlD
Decamethonium—ACHE—adrenal gland—breast cancer	0.000935	0.0309	CbGeAlD
Decamethonium—CHRNB1—lymph node—breast cancer	0.000647	0.0214	CbGeAlD
Decamethonium—BCHE—skin of body—breast cancer	0.000603	0.0199	CbGeAlD
Decamethonium—CHRM2—endocrine gland—breast cancer	0.0006	0.0198	CbGeAlD
Decamethonium—BCHE—endometrium—breast cancer	0.000569	0.0188	CbGeAlD
Decamethonium—ACHE—lymph node—breast cancer	0.000561	0.0185	CbGeAlD
Decamethonium—BCHE—uterus—breast cancer	0.000524	0.0173	CbGeAlD
Decamethonium—BCHE—pituitary gland—breast cancer	0.000515	0.017	CbGeAlD
Decamethonium—BCHE—adipose tissue—breast cancer	0.000513	0.0169	CbGeAlD
Decamethonium—BCHE—female reproductive system—breast cancer	0.000471	0.0156	CbGeAlD
Decamethonium—BCHE—adrenal gland—breast cancer	0.00046	0.0152	CbGeAlD
Decamethonium—BCHE—bone marrow—breast cancer	0.000445	0.0147	CbGeAlD
Decamethonium—BCHE—endocrine gland—breast cancer	0.000399	0.0132	CbGeAlD
Decamethonium—BCHE—lymph node—breast cancer	0.000276	0.0091	CbGeAlD
Decamethonium—BCHE—Metabolism—NQO1—breast cancer	1.52e-05	0.000149	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—RGS2—breast cancer	1.52e-05	0.000149	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—CCL20—breast cancer	1.5e-05	0.000147	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—AGTR1—breast cancer	1.5e-05	0.000147	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—PIK3CD—breast cancer	1.49e-05	0.000146	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	1.49e-05	0.000146	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of proteins—MMP2—breast cancer	1.49e-05	0.000146	CbGpPWpGaD
Decamethonium—BCHE—Neuronal System—HRAS—breast cancer	1.48e-05	0.000145	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—CYP3A4—breast cancer	1.48e-05	0.000145	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—ITPR1—breast cancer	1.48e-05	0.000145	CbGpPWpGaD
Decamethonium—HRH3—GPCR downstream signaling—PIK3CA—breast cancer	1.47e-05	0.000145	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	1.47e-05	0.000145	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—SERPINE1—breast cancer	1.47e-05	0.000144	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—KRAS—breast cancer	1.46e-05	0.000143	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—CYP1B1—breast cancer	1.46e-05	0.000143	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—LPAR1—breast cancer	1.45e-05	0.000143	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—TLE3—breast cancer	1.45e-05	0.000143	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.44e-05	0.000141	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—HEY1—breast cancer	1.44e-05	0.000141	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—HSP90AA1—breast cancer	1.43e-05	0.00014	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—COMT—breast cancer	1.43e-05	0.00014	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—GSTP1—breast cancer	1.42e-05	0.000139	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—DLL1—breast cancer	1.41e-05	0.000138	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—NOS3—breast cancer	1.41e-05	0.000138	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—HMOX1—breast cancer	1.4e-05	0.000137	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—ITPR1—breast cancer	1.4e-05	0.000137	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—NCOA1—breast cancer	1.39e-05	0.000136	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—HIST1H2BK—breast cancer	1.39e-05	0.000136	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—HIST1H2BC—breast cancer	1.39e-05	0.000136	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of proteins—CXCL8—breast cancer	1.38e-05	0.000136	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—GRB7—breast cancer	1.37e-05	0.000135	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—PDE4D—breast cancer	1.37e-05	0.000135	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—CYP19A1—breast cancer	1.37e-05	0.000134	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—STK11—breast cancer	1.37e-05	0.000134	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—CSF2—breast cancer	1.37e-05	0.000134	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—TAB2—breast cancer	1.35e-05	0.000132	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—ABCB1—breast cancer	1.34e-05	0.000132	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—ITPR1—breast cancer	1.34e-05	0.000132	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—PIK3CA—breast cancer	1.34e-05	0.000131	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—CNR2—breast cancer	1.34e-05	0.000131	CbGpPWpGaD
Decamethonium—CHRM2—GPCR ligand binding—CXCL8—breast cancer	1.34e-05	0.000131	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—MMP3—breast cancer	1.33e-05	0.000131	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—MDM2—breast cancer	1.33e-05	0.000131	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—RAF1—breast cancer	1.33e-05	0.00013	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—RELA—breast cancer	1.32e-05	0.00013	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—TYMS—breast cancer	1.32e-05	0.000129	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—ERBB2—breast cancer	1.32e-05	0.000129	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—DKK1—breast cancer	1.31e-05	0.000128	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—NCOR1—breast cancer	1.31e-05	0.000128	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—GSTM1—breast cancer	1.31e-05	0.000128	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—PLA2G4A—breast cancer	1.31e-05	0.000128	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—PIK3CB—breast cancer	1.3e-05	0.000127	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—MTOR—breast cancer	1.3e-05	0.000127	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—VEGFC—breast cancer	1.3e-05	0.000127	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.29e-05	0.000126	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of proteins—CTNNB1—breast cancer	1.28e-05	0.000125	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—JAG2—breast cancer	1.28e-05	0.000125	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—COMT—breast cancer	1.27e-05	0.000125	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—GSTP1—breast cancer	1.27e-05	0.000124	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—WNT1—breast cancer	1.26e-05	0.000123	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—PLA2G4A—breast cancer	1.26e-05	0.000123	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—GPX1—breast cancer	1.25e-05	0.000123	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—HMOX1—breast cancer	1.25e-05	0.000123	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—CXCL8—breast cancer	1.25e-05	0.000122	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—ITPR1—breast cancer	1.25e-05	0.000122	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—CSF2—breast cancer	1.24e-05	0.000122	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—HRAS—breast cancer	1.24e-05	0.000121	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—CYP1A1—breast cancer	1.24e-05	0.000121	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of proteins—CXCL8—breast cancer	1.24e-05	0.000121	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—ERCC2—breast cancer	1.23e-05	0.00012	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—CDKN1B—breast cancer	1.22e-05	0.000119	CbGpPWpGaD
Decamethonium—HRH3—GPCR downstream signaling—AKT1—breast cancer	1.2e-05	0.000118	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—ABCB1—breast cancer	1.2e-05	0.000118	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—CASP3—breast cancer	1.19e-05	0.000117	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—NOTCH4—breast cancer	1.19e-05	0.000117	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—IL2—breast cancer	1.19e-05	0.000117	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—IL6—breast cancer	1.19e-05	0.000116	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—GZMB—breast cancer	1.19e-05	0.000116	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—TYMS—breast cancer	1.18e-05	0.000116	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—PLA2G4A—breast cancer	1.16e-05	0.000114	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—GSTM1—breast cancer	1.16e-05	0.000114	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—NCOR1—breast cancer	1.16e-05	0.000114	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—CCND1—breast cancer	1.16e-05	0.000114	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—JUN—breast cancer	1.16e-05	0.000114	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—MTHFR—breast cancer	1.15e-05	0.000113	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—CXCL2—breast cancer	1.15e-05	0.000113	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—AGTR2—breast cancer	1.15e-05	0.000113	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—CTNNB1—breast cancer	1.15e-05	0.000113	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of proteins—CTNNB1—breast cancer	1.14e-05	0.000112	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—PTHLH—breast cancer	1.14e-05	0.000112	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—BMP2—breast cancer	1.14e-05	0.000112	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—MMP9—breast cancer	1.13e-05	0.000111	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—CDKN1A—breast cancer	1.12e-05	0.00011	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—PTEN—breast cancer	1.12e-05	0.00011	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—GPX1—breast cancer	1.12e-05	0.000109	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—CYP1A1—breast cancer	1.1e-05	0.000108	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—EDNRB—breast cancer	1.1e-05	0.000108	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—MAPK8—breast cancer	1.1e-05	0.000108	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—ERCC2—breast cancer	1.09e-05	0.000107	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—AKT1—breast cancer	1.09e-05	0.000107	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—PGR—breast cancer	1.09e-05	0.000107	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—THBS1—breast cancer	1.09e-05	0.000106	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—CAV1—breast cancer	1.06e-05	0.000104	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—SRC—breast cancer	1.04e-05	0.000102	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—FLT1—breast cancer	1.04e-05	0.000102	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—SQSTM1—breast cancer	1.03e-05	0.000101	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—FGF3—breast cancer	1.03e-05	0.000101	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—MTHFR—breast cancer	1.03e-05	0.000101	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—PIK3CG—breast cancer	1.03e-05	0.000101	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—JAG1—breast cancer	1.02e-05	9.98e-05	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.02e-05	9.97e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—PARP1—breast cancer	1.01e-05	9.94e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—NOTCH3—breast cancer	1.01e-05	9.94e-05	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—VEGFA—breast cancer	1.01e-05	9.93e-05	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—STAT3—breast cancer	1e-05	9.83e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—CALCA—breast cancer	1e-05	9.82e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—RPS6—breast cancer	9.9e-06	9.7e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—FGF4—breast cancer	9.82e-06	9.63e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—CXCR4—breast cancer	9.78e-06	9.59e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—CXCL12—breast cancer	9.78e-06	9.59e-05	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—PIK3CG—breast cancer	9.69e-06	9.5e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—PAK1—breast cancer	9.6e-06	9.42e-05	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—MAPK3—breast cancer	9.58e-06	9.4e-05	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—CAV1—breast cancer	9.49e-06	9.31e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—TCF7L2—breast cancer	9.43e-06	9.25e-05	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—AKT2—breast cancer	9.39e-06	9.21e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—PIK3CG—breast cancer	9.32e-06	9.14e-05	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—MYC—breast cancer	9.32e-06	9.14e-05	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—TGFB1—breast cancer	9.3e-06	9.12e-05	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—EGFR—breast cancer	9.12e-06	8.94e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—HSP90AA1—breast cancer	9.1e-06	8.92e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—NOTCH2—breast cancer	9.1e-06	8.92e-05	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	9.07e-06	8.89e-05	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—PIK3CD—breast cancer	9.02e-06	8.85e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—PRL—breast cancer	8.85e-06	8.68e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—AGTR1—breast cancer	8.85e-06	8.68e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—STK11—breast cancer	8.72e-06	8.55e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—ADAM10—breast cancer	8.72e-06	8.55e-05	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—PIK3CG—breast cancer	8.65e-06	8.48e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—PLG—breast cancer	8.62e-06	8.45e-05	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—KRAS—breast cancer	8.61e-06	8.44e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—AKT2—breast cancer	8.53e-06	8.36e-05	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—PIK3CD—breast cancer	8.52e-06	8.35e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—FGF10—breast cancer	8.48e-06	8.32e-05	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—ALB—breast cancer	8.41e-06	8.25e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—PIK3CD—breast cancer	8.19e-06	8.03e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—PDGFA—breast cancer	8.19e-06	8.03e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—TGFBR2—breast cancer	8.07e-06	7.91e-05	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—NOS3—breast cancer	8.05e-06	7.89e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—ITPR1—breast cancer	7.94e-06	7.78e-05	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—PIK3CA—breast cancer	7.91e-06	7.76e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—MMP3—breast cancer	7.89e-06	7.73e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—ERBB4—breast cancer	7.89e-06	7.73e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—STAT5A—breast cancer	7.89e-06	7.73e-05	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—PIK3CB—breast cancer	7.86e-06	7.71e-05	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—TP53—breast cancer	7.65e-06	7.5e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—SMAD4—breast cancer	7.64e-06	7.49e-05	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—PIK3CD—breast cancer	7.6e-06	7.45e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—IGF1R—breast cancer	7.59e-06	7.44e-05	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—CXCL8—breast cancer	7.56e-06	7.41e-05	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—ALB—breast cancer	7.5e-06	7.36e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—HES1—breast cancer	7.46e-06	7.31e-05	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—PIK3CB—breast cancer	7.43e-06	7.28e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—NCOR1—breast cancer	7.41e-06	7.27e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—PLA2G4A—breast cancer	7.41e-06	7.27e-05	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—PTGS2—breast cancer	7.36e-06	7.22e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—FGF1—breast cancer	7.33e-06	7.19e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—CSF2—breast cancer	7.33e-06	7.19e-05	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—HRAS—breast cancer	7.32e-06	7.18e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—RAF1—breast cancer	7.31e-06	7.17e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—NRG1—breast cancer	7.28e-06	7.14e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—H2AFX—breast cancer	7.23e-06	7.08e-05	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—IL2—breast cancer	7.22e-06	7.08e-05	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—NOS3—breast cancer	7.18e-06	7.04e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—E2F1—breast cancer	7.17e-06	7.03e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—PIK3CB—breast cancer	7.14e-06	7e-05	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—IL6—breast cancer	7.01e-06	6.87e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—SPP1—breast cancer	6.89e-06	6.76e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—CXCL8—breast cancer	6.86e-06	6.73e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—ERBB3—breast cancer	6.82e-06	6.68e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—FGFR2—breast cancer	6.81e-06	6.67e-05	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—PIK3CB—breast cancer	6.63e-06	6.5e-05	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—PTGS2—breast cancer	6.56e-06	6.44e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—IL2—breast cancer	6.56e-06	6.43e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—TERT—breast cancer	6.53e-06	6.41e-05	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—AKT1—breast cancer	6.46e-06	6.34e-05	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—PTEN—breast cancer	6.42e-06	6.29e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—FGFR1—breast cancer	6.34e-06	6.22e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—HIF1A—breast cancer	6.25e-06	6.13e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—LEP—breast cancer	6.1e-06	5.98e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—CAV1—breast cancer	6.04e-06	5.93e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—KDR—breast cancer	5.98e-06	5.86e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—ESR1—breast cancer	5.82e-06	5.71e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—FN1—breast cancer	5.75e-06	5.64e-05	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—PTEN—breast cancer	5.73e-06	5.61e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—NFKBIA—breast cancer	5.68e-06	5.57e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—NOTCH1—breast cancer	5.63e-06	5.52e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—KIT—breast cancer	5.51e-06	5.4e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—APC—breast cancer	5.51e-06	5.4e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—PIK3CG—breast cancer	5.51e-06	5.4e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—EGF—breast cancer	5.44e-06	5.34e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—MAPK3—breast cancer	5.27e-06	5.17e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—BRAF—breast cancer	5.18e-06	5.07e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—IGF1—breast cancer	5.04e-06	4.94e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—AKT2—breast cancer	5.04e-06	4.94e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—EGFR—breast cancer	5.02e-06	4.92e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—PIK3CD—breast cancer	4.84e-06	4.75e-05	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—PIK3CA—breast cancer	4.79e-06	4.7e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—SERPINE1—breast cancer	4.79e-06	4.69e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—KRAS—breast cancer	4.74e-06	4.65e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—NOS3—breast cancer	4.57e-06	4.48e-05	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—PIK3CA—breast cancer	4.53e-06	4.44e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—PIK3CA—breast cancer	4.35e-06	4.27e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—MDM2—breast cancer	4.34e-06	4.25e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—RAF1—breast cancer	4.32e-06	4.24e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—RELA—breast cancer	4.3e-06	4.22e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—ERBB2—breast cancer	4.27e-06	4.19e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—MTOR—breast cancer	4.22e-06	4.14e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—PIK3CB—breast cancer	4.22e-06	4.14e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—CXCL8—breast cancer	4.05e-06	3.97e-05	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—PIK3CA—breast cancer	4.04e-06	3.96e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—HRAS—breast cancer	4.03e-06	3.95e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—CDKN1B—breast cancer	3.96e-06	3.88e-05	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—AKT1—breast cancer	3.92e-06	3.84e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—CASP3—breast cancer	3.88e-06	3.8e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—IL2—breast cancer	3.87e-06	3.8e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—IL6—breast cancer	3.85e-06	3.78e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—CCND1—breast cancer	3.78e-06	3.7e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—JUN—breast cancer	3.77e-06	3.7e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—CTNNB1—breast cancer	3.74e-06	3.67e-05	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—AKT1—breast cancer	3.7e-06	3.63e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—MMP9—breast cancer	3.67e-06	3.6e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—CDKN1A—breast cancer	3.65e-06	3.58e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—PTEN—breast cancer	3.65e-06	3.57e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—MAPK8—breast cancer	3.57e-06	3.5e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—AKT1—breast cancer	3.56e-06	3.49e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—SRC—breast cancer	3.38e-06	3.31e-05	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—AKT1—breast cancer	3.3e-06	3.24e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—VEGFA—breast cancer	3.29e-06	3.23e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—STAT3—breast cancer	3.26e-06	3.2e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—MAPK3—breast cancer	3.11e-06	3.05e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—MYC—breast cancer	3.03e-06	2.97e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—TGFB1—breast cancer	3.02e-06	2.96e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—EGFR—breast cancer	2.96e-06	2.91e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—KRAS—breast cancer	2.8e-06	2.74e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—PIK3CA—breast cancer	2.57e-06	2.52e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—TP53—breast cancer	2.49e-06	2.44e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—HRAS—breast cancer	2.38e-06	2.33e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—IL6—breast cancer	2.28e-06	2.23e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—AKT1—breast cancer	2.1e-06	2.06e-05	CbGpPWpGaD
